Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Emanuele Focà; Andrea CALCAGNO; Andrea Bonito; MARCO SIMIELE; Elisabetta Domenighini; ANTONIO D'AVOLIO; Eugenia Quiros Roldan; Laura TRENTINI; Salvatore Casari; Giovanni DI PERRI; Francesco Castelli; Stefano BONORA

doi:10.1093/jac/dkx274

Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Emanuele Focà
, Andrea CALCAGNO
, Andrea Bonito
, MARCO SIMIELE
, Elisabetta Domenighini
, ANTONIO D'AVOLIO
, Eugenia Quiros Roldan
, Laura TRENTINI
, Salvatore Casari
, Giovanni DI PERRI
, Francesco Castelli
, Stefano BONORA

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

Lingua originale	Inglese
pagine (da-a)	3163-3166
Numero di pagine	4
Rivista	Journal of Antimicrobial Chemotherapy
Volume	72
Numero di pubblicazione	11
DOI	https://doi.org/10.1093/jac/dkx274
Stato di pubblicazione	Pubblicato - 2017

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Accesso al documento

10.1093/jac/dkx274

https://hdl.handle.net/11579/216863

Altri file e collegamenti

handle

Cita questo

Focà, E., CALCAGNO, A., Bonito, A., SIMIELE, MARCO., Domenighini, E., D'AVOLIO, ANTONIO., Quiros Roldan, E., TRENTINI, L., Casari, S., DI PERRI, G., Castelli, F., & BONORA, S. (2017). Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients. Journal of Antimicrobial Chemotherapy, 72(11), 3163-3166. https://doi.org/10.1093/jac/dkx274

@article{ca3948dd312c46dfa58d8e4bbf20e1ed,

title = "Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients",

abstract = "Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.",

author = "Emanuele Foc{\`a} and Andrea CALCAGNO and Andrea Bonito and MARCO SIMIELE and Elisabetta Domenighini and ANTONIO D'AVOLIO and \{Quiros Roldan\}, Eugenia and Laura TRENTINI and Salvatore Casari and \{DI PERRI\}, Giovanni and Francesco Castelli and Stefano BONORA",

year = "2017",

doi = "10.1093/jac/dkx274",

language = "English",

volume = "72",

pages = "3163--3166",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "11",

}

Focà, E, CALCAGNO, A, Bonito, A, SIMIELE, MARCO, Domenighini, E, D'AVOLIO, ANTONIO, Quiros Roldan, E, TRENTINI, L, Casari, S, DI PERRI, G, Castelli, F & BONORA, S 2017, 'Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients', Journal of Antimicrobial Chemotherapy, vol. 72, n. 11, pagg. 3163-3166. https://doi.org/10.1093/jac/dkx274

TY - JOUR

T1 - Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

AU - Focà, Emanuele

AU - CALCAGNO, Andrea

AU - Bonito, Andrea

AU - SIMIELE, MARCO

AU - Domenighini, Elisabetta

AU - D'AVOLIO, ANTONIO

AU - Quiros Roldan, Eugenia

AU - TRENTINI, Laura

AU - Casari, Salvatore

AU - DI PERRI, Giovanni

AU - Castelli, Francesco

AU - BONORA, Stefano

PY - 2017

Y1 - 2017

N2 - Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

AB - Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

UR - https://iris.uniupo.it/handle/11579/216863

U2 - 10.1093/jac/dkx274

DO - 10.1093/jac/dkx274

M3 - Article

SN - 0305-7453

VL - 72

SP - 3163

EP - 3166

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 11

ER -

Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Abstract

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo